Physio-Control
This article was originally published in The Gray Sheet
Executive Summary
Lilly reaches agreement in principle to sell its Physio-Control subsidiary to the private equity investment firm Bain Capital. Financial terms of the deal, which is expected to close by Aug. 1, were not disclosed. The companies indicated that management at the external defibrillator manufacturer is likely to remain intact. Regarding Physio-Control's 900 employees, Lilly said that "Bain has a philosophy that is consistent with Lilly's, including personnel policies and programs that recognize the value of employees." Lilly is forming a new company (Guidant) that will include five of its nine medical device/diagnostic businesses and currently is in negotiations for sale of the remaining three businesses -- Hybritech, IVAC and Pacific Biotech ("The Gray Sheet" June 27, p. 17)
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.